If you make a purchase via links on this page we will earn commission - learn more Pasty, potato-faced, knackered: my ...

The Chicago Cubs got a bit of help from the man in the mask during Thursday’s winner-take-all game. Chicago met the San Diego Padres for the decisive Game 3 of their best-of-three NL Wild Card Series ...

The Federal Reserve is in the middle of a delicate tango between inflation and interest rates. The most recent rate cut was modest, and Wall Street seems to believe it was just the start. Rate cuts ...

The increase is in accordance with the accepted formula based on the recommendations of the 7th Central Pay Commission.

The Cincinnati Bengals aren't giving up on their season quite yet. After three straight losses in the absence of starting QB Joe Burrow, the Bengals have traded for veteran Joe Flacco. Flacco, 40, is ...

The Chicago Cubs got a bit of help from the man in the mask during Thursday’s winner-take-all game. Chicago met the San Diego Padres for the decisive Game 3 of their best-of-five NL Wild Card Series ...

With Congress gridlocked over spending bills, the US faces a looming government shutdown that could begin as early as this week. While most sectors brace for disruption, a handful of companies stand ...

Chancellor Rachel Reeves is expected to lift the two-child benefit cap. (Alamy) Education secretary Bridget Phillipson has given the clearest sign yet that the two-child benefit cap could be scrapped, ...

Target's higher-quality focus is losing out to Walmart's everyday low prices, but happier consumers could shift back. Lululemon Athletica is a luxury clothing maker that could see demand pick up if ...

They say you can’t teach an old dog new tricks—but that’s simply not true. No matter your dog’s age, breed, size, or background, they’re always capable of learning something new. With a little ...

• The Bank of Canada's rate cuts to 2.5% should significantly benefit highly leveraged companies like BCE (TSX:BCE) with $32 billion in debt, Northwest Healthcare REIT (TSX:NWH.UN) with $2 billion in ...

BridgeBio Pharma recently presented new Phase 3 data showing that acoramidis (marketed as Attruby) led to a significant reduction in cardiovascular mortality and recurrent hospitalizations in patients ...